Finance

Lists
4568:TYO
Daiichi Sankyo Co Ltd
JP¥2.745,50
-1,24%
(-34,50) 1D
18 ພ.ຈ., 9 ໂມງ 58 ນາທີ 56 ວິນາທີ GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4568...
Open
JP¥2.745
High
JP¥2.755
Low
JP¥2.716
Mkt. cap
5,11 ລ້ານລ້ານ
Avg. vol.
8,24 ລ້ານ
Volume
1,48 ລ້ານ
Dividend
3,24%
Quarterly dividend
JP¥22
P/E ratio
17,94
52-wk high
JP¥3.913
52-wk low
JP¥2.390
EPS
JP¥153
Shares outstanding
647,77 ລ້ານ
No. of employees
20 ພັນ
Open
JP¥2.745
High
JP¥2.755
Low
JP¥2.716
Mkt. cap
5,11 ລ້ານລ້ານ
Avg. vol.
8,24 ລ້ານ
Volume
1,48 ລ້ານ
Dividend
3,24%
Quarterly dividend
JP¥22
P/E ratio
17,94
52-wk high
JP¥3.913
52-wk low
JP¥2.390
EPS
JP¥153
Shares outstanding
647,77 ລ້ານ
No. of employees
20 ພັນ
News stories
From web sources and news partners
ChartMill
ChartMill
·
3 ຊົ່ວໂມງກ່ອນ
S&P 500 After-Hours Gainers for Nov. 17, 2026
www.tmgm.com
www.tmgm.com
·
3 ຊົ່ວໂມງກ່ອນ
NSA outage sends Dow Jones Industrial Average lower before Nvidia beats
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey. Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries. Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees20,2 ພັນ
Founded28 ກ.ຍ. 2005
HeadquartersChuo City, ໂຕກຽວ, ຍີ່ປຸ່ນ
Sector-
Industry-
Last report
30 ຕ.ລ. 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
592,49 ຕື້ / 568,07 ຕື້
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
ກ.ຍ. 2026
Revenue
558,11 ຕື້
589,59 ຕື້
574,74 ຕື້
592,49 ຕື້
Cost of goods sold
118,28 ຕື້
302,44 ຕື້
124,29 ຕື້
121,50 ຕື້
Cost of revenue
118,28 ຕື້
302,44 ຕື້
124,29 ຕື້
121,50 ຕື້
Research and development expenses
122,11 ຕື້
126,23 ຕື້
115,46 ຕື້
124,60 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
228,23 ຕື້
154,06 ຕື້
249,96 ຕື້
237,75 ຕື້
Operating expense
350,29 ຕື້
279,38 ຕື້
365,35 ຕື້
362,29 ຕື້
Total operating expenses
468,57 ຕື້
581,82 ຕື້
489,64 ຕື້
483,79 ຕື້
Operating income
89,54 ຕື້
7,77 ຕື້
85,10 ຕື້
108,70 ຕື້
Other non operating income
-
6,22 ຕື້
-2,00 ລ້ານ
-
EBT including unusual items
106,73 ຕື້
22,44 ຕື້
91,34 ຕື້
101,51 ຕື້
EBT excluding unusual items
106,73 ຕື້
7,84 ຕື້
91,34 ຕື້
101,51 ຕື້
Income tax expense
20,10 ຕື້
-39,84 ຕື້
22,70 ຕື້
17,10 ຕື້
Effective tax rate
18,83%
-177,52%
24,86%
16,84%
Other operating expenses
-49,00 ລ້ານ
-908,00 ລ້ານ
-69,00 ລ້ານ
-60,00 ລ້ານ
Net income
86,63 ຕື້
62,28 ຕື້
68,64 ຕື້
82,90 ຕື້
Net profit margin
15,52%
10,56%
11,94%
13,99%
Earnings per share
-
-
-
-
Interest and investment income
19,08 ຕື້
377,00 ລ້ານ
9,74 ຕື້
6,41 ຕື້
Interest expense
-2,16 ຕື້
-18,91 ຕື້
-3,23 ຕື້
-14,13 ຕື້
Net interest expenses
16,91 ຕື້
-18,53 ຕື້
6,51 ຕື້
-7,72 ຕື້
Depreciation and amortization charges
-
-
-
-
EBITDA
109,18 ຕື້
28,89 ຕື້
106,58 ຕື້
130,56 ຕື້
Gain or loss from assets sale
573,00 ລ້ານ
8,50 ຕື້
180,00 ລ້ານ
3,24 ຕື້
Upcoming events
AI content may include mistakes. Learn more
ແອັບຂອງ Google